Company Profile
ICON Clinical Research
Company Overview
ICON Development Solutions specializes in the strategy and delivery of early phase clinical development for informed, timely decision making. With expertise in early phase clinical research, bioanalytical, PK/PD modelling & simulation and the full range of supporting services, we incorporate scientific excellence and product development strategy in all that we do. Our multi-disciplinary experts have the experience to address the most demanding drug development challenges with an unyielding focus on completing clinical studies on time, on budget and with the quality that will withstand the most vigorous scrutiny.
Company History
From a small team of 5 people in 1990, ICON now employs over 10,000 people across 79 offices in 37 countries. We have mainly grown organically, but have bolstered our growth through a number of strategic acquisitions which have broadened our service portfolio and have added scale to existing services.
Key Company Milestones:
1990 - ICON founded in Dublin, Ireland, by Dr. John Climax & Dr. Ronan Lambe
1991 - ICON opens its first overseas office in Winchester, UK
1992 - ICON opens its first US office in Philadelphia
1994 - ICON becomes first CRO to be awarded the ISO 9001 certification
1996 - ICON opens its first Asian office in Tokyo, Japan
1998 - ICON IPO’s and begins trading on the NASDAQ exchange
1998 - ICON opens its first South American office in Buenos Aires, Argentina
2000 - ICON acquires UK-based regulatory consultancy
2000 - ICON acquires Central Laboratory in New York
2002 - ICON acquires staffing group Managed Clinical Solutions
2002 - ICON opens first African office in South Africa
2003 - ICON acquires Medeval, a UK-based Phase I facility
2003 - ICON acquires US consulting firm Globomax
2004 - ICON acquires 70% interest in Medical Imaging specialist Beacon Bioscience Inc.
2005 - ICON opens first Indian office in Chennai
2006 - ICON acquires Outcomes Research and Health Economics specialist, Ovation Research Group
2007 - ICON acquires European Staffing group DOCS International
2008 - ICON acquires US Phase I Provider Healthcare Discoveries
2008 - ICON acquires US Bioanlytical Lab, Prevalere Life Sciences
2009 - ICON acquires Veeda Laboratories, a UK Biomarker Lab
2010 - ICON acquires Timaq Medical Imaging Inc., a Swiss Imaging Specialist.
2011 - ICON acquires Oxford Outcomes Ltd., an international health outcomes consultancy
2011 - ICON acquires Firecrest Clinical Ltd.
2012 - ICON acquires Pricespective, a global value strategy consultancy
2012 - ICON acquires BeijingWits, a Chinese CRO
2013 - ICON acquires ClinForce and Assent Consulting, Staffing and FSP providers
2013 - ICON acquires Akos an EU Provider of Pharmacovigilance and Drug Safety Services.